These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 10869880)
1. Lamotrigine in the treatment of chronic refractory neuropathic pain. Devulder J; De Laat M J Pain Symptom Manage; 2000 May; 19(5):398-403. PubMed ID: 10869880 [TBL] [Abstract][Full Text] [Related]
2. The use of lamotrigine in neuropathic pain. di Vadi PP; Hamann W Anaesthesia; 1998 Aug; 53(8):808-9. PubMed ID: 9797526 [TBL] [Abstract][Full Text] [Related]
3. Cancer pain. O'Neill WM Middle East J Anaesthesiol; 1996 Feb; 13(4):373-8. PubMed ID: 8713631 [TBL] [Abstract][Full Text] [Related]
4. Opioid rotation from high-dose morphine to transdermal buprenorphine (Transtec) in chronic pain patients. Freye E; Anderson-Hillemacher A; Ritzdorf I; Levy JV Pain Pract; 2007 Jun; 7(2):123-9. PubMed ID: 17559481 [TBL] [Abstract][Full Text] [Related]
5. Lamotrigine in refractory cancer pain. A case report. Devulder JE J Clin Anesth; 2000 Nov; 12(7):574-5. PubMed ID: 11221660 [No Abstract] [Full Text] [Related]
6. 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double-blind, placebo controlled trial. McCleane G Pain; 1999 Oct; 83(1):105-7. PubMed ID: 10506679 [TBL] [Abstract][Full Text] [Related]
7. No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients. Riley J; Ross JR; Rutter D; Wells AU; Goller K; du Bois R; Welsh K Support Care Cancer; 2006 Jan; 14(1):56-64. PubMed ID: 15952009 [TBL] [Abstract][Full Text] [Related]
8. Lamotrigine in the management of neuropathic pain: a review of the literature. McCleane GJ Clin J Pain; 2000 Dec; 16(4):321-6. PubMed ID: 11153788 [TBL] [Abstract][Full Text] [Related]
11. Lamotrigine control of central pain. Canavero S; Bonicalzi V Pain; 1996 Nov; 68(1):179-181. PubMed ID: 9252013 [TBL] [Abstract][Full Text] [Related]
12. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit. Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298 [TBL] [Abstract][Full Text] [Related]
13. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Anderson VC; Burchiel KJ Neurosurgery; 1999 Feb; 44(2):289-300; discussion 300-1. PubMed ID: 9932882 [TBL] [Abstract][Full Text] [Related]
14. Lamotrigine as an augmentation agent in treatment-resistant depression. Barbee JG; Jamhour NJ J Clin Psychiatry; 2002 Aug; 63(8):737-41. PubMed ID: 12197456 [TBL] [Abstract][Full Text] [Related]
15. Open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic pain. Webster LR; Fakata KL; Charapata S; Fisher R; MineHart M Pain Med; 2008 Apr; 9(3):282-90. PubMed ID: 18366508 [TBL] [Abstract][Full Text] [Related]
16. A comparison of the glutamate release inhibition and anti-allodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain. Coderre TJ; Kumar N; Lefebvre CD; Yu JS J Neurochem; 2007 Mar; 100(5):1289-99. PubMed ID: 17241130 [TBL] [Abstract][Full Text] [Related]
17. Opioid and adjuvant analgesics: compared and contrasted. Khan MI; Walsh D; Brito-Dellan N Am J Hosp Palliat Care; 2011 Aug; 28(5):378-83. PubMed ID: 21622486 [TBL] [Abstract][Full Text] [Related]
18. Use of morphine and adjuvant drugs according to the condition. Matoba M Eur J Pain; 2001; 5 Suppl A():59-62. PubMed ID: 11798219 [TBL] [Abstract][Full Text] [Related]
19. Morphine, gabapentin, or their combination for neuropathic pain. Gilron I; Bailey JM; Tu D; Holden RR; Weaver DF; Houlden RL N Engl J Med; 2005 Mar; 352(13):1324-34. PubMed ID: 15800228 [TBL] [Abstract][Full Text] [Related]